Bill Sponsor
BILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 3153
116th Congress(2019-2020)
Expanding Findings for Federal Opioid Research and Treatment Act
Became Law
Amendments
Became Law
Became Public Law 116-335 on Jan 13, 2021
Overview
Text
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 3153 (Reported-in-Senate)

Calendar No. 510

116th CONGRESS
2d Session
H. R. 3153

[Report No. 116–248]


To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes.

IN THE SENATE OF THE UNITED STATES

July 24, 2019

Received; read twice and referred to the Committee on Commerce, Science, and Transportation

August 6, 2020

Reported by Mr. Wicker, with an amendment

[Strike out all after the enacting clause and insert the part printed in italic]

AN ACT

To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title; findings.

(a) Short title.—This Act may be cited as the “Expanding Findings for Federal Opioid Research and Treatment Act” or the “EFFORT Act”.

(b) Findings.—The Congress finds that—

(1) research gaps currently exist in the prevention and treatment of opioid addiction;

(2) the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and

(3) the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.

SEC. 2. NSF support of research on opioid addiction.

The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively awarded research on the science of opioid addiction.

SECTION 1. Short title; findings.

(a) Short title.—This Act may be cited as the “Expanding Findings for Federal Opioid Research and Treatment Act” or the “EFFORT Act”.

(b) Findings.—Congress finds that—

(1) research gaps exist in the prevention and treatment of opioid addiction;

(2) the National Science Foundation’s research on opioid addiction has increased understanding of the neuroscience of addiction, substance abuse intervention, the role of illicit supply networks, the secondary effects on families, the use of technology to address the opioid epidemic, and options for alternative, non-addictive therapeutics for pain; and

(3) the National Science Foundation and the National Institutes of Health have recognized that fundamental questions in basic, clinical, and translational research would benefit greatly from multidisciplinary approaches and collaboration.

SEC. 2. NSF support of research on opioid addiction.

(a) In general.—The Director of the National Science Foundation, in consultation with the Director of the National Institutes of Health, shall support merit-reviewed and competitively-awarded research on the science of opioid addiction.

(b) Authorization of appropriations.—To carry out this section, there are authorized to be appropriated $10,000,000 for each of fiscal years 2020 through 2024.

Calendar No. 510

116th CONGRESS
     2d Session
H. R. 3153
[Report No. 116–248]
AN ACT
To direct the Director of the National Science Foundation to support research on opioid addiction, and for other purposes.
August 6, 2020
Reported with an amendment